A Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via TWISTHALER® Device in Adult and Adolescent Patients With Persistent Asthma

NCT00545272 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

392

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: indacaterol
DRUG: formoterol
DRUG: placebo to indacaterol
DRUG: placebo to formoterol
DRUG: short acting β2-agonist

Sponsor

Novartis Pharmaceuticals

Collaborators

[object Object]